Method for restoration of normal phenotype in cancer cells
AssigneeThe Regents of the University of California
InventorsMina J. Bissell, Valerie M. Weaver
Life of this patent
Estimating the term…
Abstract
A method for reversing expression of malignant phenotype in cancer cells is described. The method comprises applying .beta..sub.1 integrin function-blocking antibody to the cells. The method can be used to assess the progress of cancer therapy. Human breast epithelial cells were shown to be particularly responsive.
Claims9
A method for reversing malignant phenotype in tissue by administering an effective amount of an .beta..sub.1 integrin function-blocking antibody or a peptide inhibitor of integrin function to the .beta..sub.1 integrin receptors of tissue in need of such treatment.
Dependencies are inferred from the claim text.